Literature DB >> 2552484

Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography.

H Shinotoh1, M Iyo, T Yamada, O Inoue, K Suzuki, T Itoh, H Fukuda, T Yamasaki, Y Tateno, K Hirayama.   

Abstract

Benzodiazepine receptor occupancy in the brain following oral administration of clonazepam (CZP) with a dose of 30 micrograms/kg in six healthy young men and a further dose of 50 micrograms/kg in one of the subjects was estimated by carbon-11 labeled Ro15-1788 and positron emission tomography (PET). The effects of CZP on the latency of auditory event-related potentials (P300) were also studied. Overall brain 11C uptake was depressed and the % inhibition of 11C uptake in the gray matter of the brain at 30 min after [11C]Ro15-1788 injection was 15.3-23.5% (mean, n = 6) following 30 micrograms/kg CZP when compared with that in the control experiment without any previous treatment. The 11C uptake in the cerebral cortex in the subject who received both doses decreased in a dose-related manner after 30 micrograms/kg and 50 micrograms/kg CZP. The P300 latency was prolonged significantly by 30 micrograms/kg CZP [31.6 +/- 16.3 ms (mean +/- SD, n = 6), P less than 0.05]. The P300 latency in the same subject was prolonged in a dose-related manner by 30 micrograms/kg and 50 micrograms/kg CZP. The technique using [11C]Ro15-1788 and PET permits comparison of the pharmacological effects with the percentage of receptor sites which benzodiazepines occupy in the human brain. P300 also seems to be useful to investigate the pharmacological effects of benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552484     DOI: 10.1007/BF00442808

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Assay and pharmacokinetics of clonazepam in humans.

Authors:  J Naestoft; M Lund; N E Larsen; E Hvidberg
Journal:  Acta Neurol Scand Suppl       Date:  1973

2.  Determination of nitrazepam (mogadon) in plasma by electron capture gas-liquid chromatography.

Authors:  G P Beharrell; D M Hailey; M K McLaurin
Journal:  J Chromatogr       Date:  1972-07-26

3.  Effects of methylphenidate on young adults' performance and event-related potentials in a vigilance and a paired-associates learning test.

Authors:  J Strauss; J L Lewis; R Klorman; L J Peloquin; R A Perlmutter; L F Salzman
Journal:  Psychophysiology       Date:  1984-11       Impact factor: 4.016

4.  Human information-processing: some effects of methylphenidate, age, and scopolamine.

Authors:  E Callaway
Journal:  Biol Psychiatry       Date:  1984-05       Impact factor: 13.382

5.  A metric for thought: a comparison of P300 latency and reaction time.

Authors:  G McCarthy; E Donchin
Journal:  Science       Date:  1981-01-02       Impact factor: 47.728

6.  Benzodiazepine receptor occupancy in vivo: correlation with brain concentrations and pharmacodynamic actions.

Authors:  L G Miller; D J Greenblatt; S M Paul; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

7.  Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.

Authors:  Y Samson; P Hantraye; J C Baron; F Soussaline; D Comar; M Mazière
Journal:  Eur J Pharmacol       Date:  1985-04-02       Impact factor: 4.432

8.  Effects of diazepam on cognitive processes in normal subjects.

Authors:  P P Roy-Byrne; T W Uhde; H Holcomb; K Thompson; A K King; H Weingartner
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Central type benzodiazepine binding sites: a positron emission tomography study in the baboon's brain.

Authors:  P Hantraye; M Kaijima; C Prenant; B Guibert; J Sastre; M Crouzel; R Naquet; D Comar; M Maziere
Journal:  Neurosci Lett       Date:  1984-07-27       Impact factor: 3.046

10.  Regional specific binding of [11C]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET.

Authors:  S Pappata; Y Samson; C Chavoix; C Prenant; M Mazière; J C Baron
Journal:  J Cereb Blood Flow Metab       Date:  1988-06       Impact factor: 6.200

View more
  10 in total

1.  Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.

Authors:  H V Semlitsch; P Anderer; B Saletu
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).

Authors:  Charles M Laymon; Rajesh Narendran; Neale S Mason; Jonathan P Carney; Brian J Lopresti; Chester A Mathis; James M Mountz; Donald Sashin; W Gordan Frankle
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

3.  Effects of a small dose of triazolam on P300 and resting EEG.

Authors:  J Urata; M Uchiyama; M Iyo; T Enomoto; T Hayakawa; M Tomiyama; T Nakajima; H Sasaki; S Shirakawa; K Wada; S Fukui; H Yamadera; M Okawa
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 4.  Where have we got to with neuroreceptor mapping of the human brain?

Authors:  B Mazière; M Mazière
Journal:  Eur J Nucl Med       Date:  1990

5.  Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects.

Authors:  Goro Fukami; Tasuku Hashimoto; Yukihiko Shirayama; Tadashi Hasegawa; Hiroyuki Watanabe; Mihisa Fujisaki; Kenji Hashimoto; Masaomi Iyo
Journal:  Ann Gen Psychiatry       Date:  2010-11-03       Impact factor: 3.455

6.  Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes.

Authors:  Nancy A Ator; John R Atack; Richard J Hargreaves; H Donald Burns; Gerard R Dawson
Journal:  J Pharmacol Exp Ther       Date:  2009-09-29       Impact factor: 4.030

7.  Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.

Authors:  K Yanai; J H Ryu; T Watanabe; R Iwata; T Ido; Y Sawai; K Ito; M Itoh
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images.

Authors:  James F M Myers; Lula Rosso; Ben J Watson; Sue J Wilson; Nicola J Kalk; Nicoletta Clementi; David J Brooks; David J Nutt; Federico E Turkheimer; Anne R Lingford-Hughes
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

9.  GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans.

Authors:  Aurelija Jucaite; Zsolt Cselényi; Jaakko Lappalainen; Dennis J McCarthy; Chi-Ming Lee; Svante Nyberg; Katarina Varnäs; Per Stenkrona; Christer Halldin; Alan Cross; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2016-12-24       Impact factor: 4.530

Review 10.  Drug interactions at the blood-brain barrier: fact or fantasy?

Authors:  Sara Eyal; Peng Hsiao; Jashvant D Unadkat
Journal:  Pharmacol Ther       Date:  2009-04-22       Impact factor: 13.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.